Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
When it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent names often come to mind: (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY).
Both companies have a long history of paying dividends and offer attractive yields, making them popular choices among income-seeking investors. However, when comparing these two stocks, several factors should be considered to determine which one is the better high-yield dividend investment.
Image Source: Getty Images.
Source Fool.com
Pfizer Inc. Aktie
27,88 €
-1,97 %
Die Community bevorzugt Pfizer Inc., mit deutlich mehr Buy- (29) als Sell-Einschätzungen (4).
Ein Kursziel von 41 € für Pfizer Inc. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 27.88 € bedeuten.
